Ingersoll Rand vs Relay Therapeutics Inc. Common Stock — how do they compare? Ingersoll Rand trades at $78.6 (market cap $30.26B), while Relay Therapeutics Inc. Common Stock trades at $18.16 (market cap $3.82B). The key difference: Ingersoll Rand is far larger — about 7.9× Relay Therapeutics Inc. Common Stock's market cap, and Ingersoll Rand pays a 0.1% dividend while Relay Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ingersoll Rand for 7 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| IR | RLAY | |
|---|---|---|
Market Cap | $30.26B | $3.82B |
Volume | 4,017,622 | 4,332,079 |
Sector | Industrials | Health |
52-Week High | $98.76 | $20.75 |
52-Week Low | $68.54 | $6.03 |
Typical Hold Time | 7 Days | 0 Days |
Enterprise Value | $33.92B | $2.93B |
Dividend Yield | 0.1% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Ingersoll Rand develops industrial technologies for creating and managing flow, pressure, and motion. Its portfolio includes compressors, pumps, vacuum systems, and other equipment used across industrial markets.
Read more on IR →Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →